Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 27, Issue 9, 2015, Pages 1128-1136

  Joseph, Brenden ^a   Kerr, Thomas ^a,b   Puskas, Cathy M ^a,c   Montaner, Julio ^a,b   Wood, Evan ^a,b   Milloy, M J ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

adherence; antiretroviral therapy; drug users; incarceration; methadone; sex work

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; METHADONE;

ADULT; ARTICLE; CANADA; CANADIAN; CANNABIS USE; CAUCASIAN; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DRUG ABUSE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; METHADONE TREATMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTITUTION; SELF CONCEPT; SOCIAL ASPECT; SOCIAL BEHAVIOR; COMPLICATION; DRUG DEPENDENCE; FACTUAL DATABASE; MIDDLE AGED; PSYCHOLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANADA; DATABASES, FACTUAL; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS;

EID: 84943450934     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2015.1032205     Document Type: Article

References (49)

1. Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Partners PrEP Study Team. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367, 399-410. doi:10.1056/NEJMoa1108524
2. Baillargeon, J., Giordano, T. P., Rich, J. D.,Wu, Z. H.,Wells, K., Pollock, B. H., &Paar, D. P. (2009). Accessing antiretroviral therapy following release from prison. Journal of the American Medical Association, 301, 848-857. doi:10.1001/ jama.2009.202
3. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-366. doi:10.1097/00002030-200003100-00008
4. Barash, E. T., Hanson, D. L., Buskin, S. E., &Teshale, E. (2007). HIV-infected injection drug users: Health care utilization and morbidity. Journal of Health Care for the Poor and Underserved, 18, 675-686. doi:10.1353/hpu. 2007.0053
5. Beck, E. J., Mandalia, S., Williams, I., Power, A., Newson, R., Molesworth, A., Tang, A. (1999). Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997. National prospective monitoring system steering group. AIDS (London, England), 13, 2157-2164. doi:10.1097/00002030-199910220-00020
6. Caplehorn, J. R. M., Bell, J., Kleinbaum, D. G., &Gebski, V. J. (1993). Methadone dose and heroin use during maintenance treatment. Addiction, 88(1), 119-124. doi:10.1111/ j.1360-0443.1993.tb02769.x
7. Chen, N. E., Meyer, J. P., Avery, A. K., Draine, J., Flanigan, T. P., Lincoln, T., &Altice, F. L. (2011). Adherence to HIV treatment and care among previously homeless jail detainees. AIDS and Behavior, 17, 2654-2666. doi:10.1007/ s10461-011-0080-2
8. Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., Celum, C. (2010). Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. The Lancet, 375, 2092-2098. doi:10.1016/S0140-6736(10)60705-2
9. Fazel, S., &Baillargeon, J. (2011). The health of prisoners. Lancet, 377, 956-965. doi:10.1016/S0140-6736(10)61053-7
10. Flanigan, T. P., &Beckwith, C. G. (2011). The intertwined epidemics of HIV infection, incarceration, and substance abuse: A call to action. The Journal of Infectious Diseases, 203, 1201-1203. doi:10.1093/infdis/jir034
11. Grossberg, R., Zhang, Y., &Gross, R. (2004). A time-toprescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. Journal of Clinical Epidemiology, 57, 1107-1110. doi:10.1016/j.jclinepi.2004. 04.002
12. He, N., Duan, S., Ding, Y., Rou, K., McGoogan, J. M., Jia, M., Graham, S. M. (2013). Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One, 8, e77981. doi:10.1371/journal.pone.0077981. t005
13. Joseph, H., Stancliff, S., &Langrod, J. (2000). Methadone maintenance treatment (MMT): A review of historical and clinical issues. The Mount Sinai Journal of Medicine, New York, 67, 347-364.
14. Jürgens, R., Nowak, M., &Day, M. (2011). HIV and incarceration: Prisons and detention. Journal of the International AIDS Society, 14(1), 26. doi:10.1186/1758-2652-14-26
15. Kidder, D. P., Wolitski, R. J., Campsmith, M. L., &Nakamura, G. V. (2007). Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. American Journal of Public Health, 97, 2238-2245. doi:10.2105/AJPH.2006.090209
16. Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., &Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Riskfactor analysis. Lancet, 357, 1397-1401. doi:10.1016/ S0140-6736(00)04562-1
17. Krusi, A., Wood, E., Montaner, J., &Kerr, T. (2010). Social and structural determinants of HAART access and adherence among injection drug users. The International Journal on Drug Policy, 21(1), 4-9. doi:10.1016/j.drugpo.2009.08.003
18. Kurtz, S. P., Surratt, H. L., Kiley, M. C., &Inciardi, J. A. (2005). Barriers to health and social services for street-based sex workers. Journal of Health Care for the Poor and Underserved, 16, 345-361. doi:10.1353/hpu.2005.0038
19. Kushel, M. B., Colfax, G., Ragland, K., Heineman, A., Palacio, H., &Bangsberg, D. R. (2006). Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clinical Infectious Diseases, 43, 234-242. doi:10.1086/505212
20. Ledergerber, B., Egger, M., Opravil, M., Telenti, A., Hirschel, B., Battegay, M., Weber, R. (1999). Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study. Lancet, 353, 863-868.
21. Lucas, G. M., Gebo, K. A., Chaisson, R. E., &Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16, 767-774. doi:10.1097/00002030-200203 290-00012
22. Lucas, G. M., Griswold, M., Gebo, K. A., Keruly, J., Chaisson, R. E., &Moore, R. D. (2006). Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy. American Journal of Epidemiology, 163, 412-420. doi:10.1093/aje/kwj059
23. Malta, M., Magnanini, M. M. F., Strathdee, S. A., Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIVinfected drug users: A meta-analysis. AIDS and Behavior, 14, 731-747. doi:10.1007/s10461-008-9489-7
24. Malta, M., Strathdee, S. A., Magnanini, M. M. F., &Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103, 1242-1257. doi:10.1111/j.1360-0443.2008.02269.x
25. McGowan, J. P., &Shah, S. S. (2000). Prevention of perinatal HIV transmission during pregnancy. Journal of Antimicrobial Chemotherapy, 46, 657-668. doi:10.1093/jac/46. 5.657
26. Miller, C. L., Spittal, P. M., Laliberte, N., Li, K., Tyndall, M. W., O'shaughnessy, M. V., &Schechter, M. T. (2002). Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. Journal of Acquired Immune Deficiency Syndromes, 30, 335-351.
27. Milloy, M. J., Kerr, T., Buxton, J., Rhodes, T., Guillemi, S., Hogg, R., Wood, E. (2011). Dose-response effect of incarceration events on Nonadherence to HIV antiretroviral therapy among injection drug users. Journal of Infectious Diseases, 203, 1215-1221. doi:10.1093/infdis/ jir032
28. Milloy, M.-J. S., Marshall, B. D. L., Kerr, T., Buxton, J., Rhodes, T., Montaner, J., &Wood, E. (2012). Social and structural factors associated with HIV disease progression among illicit drug users: A systematic review. AIDS, 26, 1049-1063. doi:10.1097/QAD.0b013e32835221cc
29. Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., &Bangsberg, D. R. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190-1198. doi:10.1086/424008
30. Murphy, E. L., Collier, A. C., Kalish, L. A., Assmann, S. F., Para, M. F., Flanigan, T. P., Viral Activation Transfusion Study Investigators. (2001). Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Annals of Internal Medicine, 135(1), 17-26. doi:10.7326/0003-4819-135-1-200107030-00005
31. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. New England Journal of Medicine, 338, 853-860. doi:10.1056/NEJM199803263381301
32. Palepu, A., Milloy, M.-J., Kerr, T., Zhang, R., &Wood, E. (2011). Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. Journal of Urban Health, 88, 545-555. doi:10. 1007/s11524-011-9562-9
33. Palepu, A., Tyndall, M. W., Joy, R., Kerr, T., Wood, E., Press, N., &Montaner, J. S. G. (2006). Antiretroviral adherence and HIV treatment outcomes among HIV/HCV coinfected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence, 84, 188-194. doi:10.1016/j.drugalcdep.2006.02.003
34. Panos, G., Samonis, G., Alexiou, V. G., Kavarnou, G. A., Charatsis, G., &Falagas, M. E. (2008). Mortality and morbidity of HIV infected patients receiving HAART: A cohort study. Current HIV Research, 6, 257-260.
35. Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Gray R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. The New England Journal of Medicine, 342, 921-929. doi:10.1056/ NEJM200003303421303
36. Rekart, M. L. (2005). Sex-work harm reduction. Lancet, 366, 2123-2134. doi:10.1016/S0140-6736(05)67732-X
37. Small, W., Wood, E., Betteridge, G., Montaner, J., &Kerr, T. (2009). The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: A qualitative study. AIDS Care, 21, 708-714. doi:10.1080/ 09540120802511869
38. Spittal, P. M., Bruneau, J., Craib, K. J. P., Miller, C., Lamothe, F., Weber, A. E., Schechter, M. T. (2003). Surviving the sex trade: A comparison of HIV risk behaviours among streetinvolved women in two Canadian cities who inject drugs. AIDS Care, 15, 187-195. doi:10.1080/09540120310000 68335
39. Strathdee, S., Palepu, A., Cornelisse, P. G., Yip, B., O'shaughnessy, M. V., Montaner, J. S., Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547-549.
40. Strathdee, S., Patrick, D. M., Currie, S. L., Cornelisse, P. G., Rekart, M. L., Montaner, J. S., &O'Shaughnessy, M. V. (1997). Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS, 11(8), F59-F65.
41. Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Volberding, P. A. (2012). Antiretroviral treatment of adult HIV infection: 2012 recommendations of the international antiviral society-USA panel. Journal of the American Medical Association, 308, 387-402. doi:10.1001/jama.2012.7961
42. Tyndall, M. W., Currie S., Spittal P., Li, K., Wood, E., O'shaughnessy, M. V., Schechter, M. T. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17, 887-893. doi:10.1097/00002030-200304110-00014
43. Uhlmann, S., Milloy, M.-J., Kerr, T., Zhang, R., Guillemi, S., Marsh, D., Wood, E. (2010). Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction, 105, 907-913. doi:10.1111/ j.1360-0443.2010.02905.x
44. Vanwesenbeeck, I. (2001). Another decade of social scientific work on sex work: A review of research 1990-2000. Annual Review of Sex Research, 12, 242-289.
45. Wolfe, D., Carrieri, M. P., &Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376, 355-366. doi:10.1016/S0140-6736(10)60832-X
46. Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'shaughnessy, M. V., &Montaner, J. S. G. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, 810-816.
47. Wood, E., Kerr, T., Tyndall, M.W., &Montaner, J. S. G. (2008). A review of barriers and facilitators of HIV treatment among injection drug users. AIDS, 22, 1247-1256. doi:10. 1097/QAD.0b013e3282fbd1ed
48. Wood, E., Montaner, J. S. G., Yip, B., Tyndall, M.W., Schechter, M. T., O'shaughnessy, M. V., &Hogg, R. S. (2003). Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users Journal De l'Association Medicale Canadienne [Canadian Medical Association Journal], 169, 656-661.
49. Wood, E., Montaner, J. S. G., Yip, B., Tyndall, M.W., Schechter, M. T., O'shaughnessy, M. V., &Hogg, R. S. (2004). Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antiviral Therapy, 9, 229-235.